Upload
builiem
View
214
Download
0
Embed Size (px)
Citation preview
Health Care and Digital in ItalyDaniela Bianco, Partner e Responsabile Health Care Unit
Alessandro Viviani, Principal Expert Digital Strategy
INNOVATION
TECNOLOGIES
ECONOMIC RESOURCES AND
FINANCIAL ISSUES
DEMOGRAPHY AND CHRONIC DISEASES
Health Care System
2 3
1
Source: Meridiano Sanità 2017 Report, The European House-Ambrosetti
Key drivers and Health Care evolution
Source: elaboration of The European House - Ambrosetti on Ministry of Economy and Finance data, 2018
Trend of the ratio between healthcare expenditure and GDP (%), 2007 - 2021
In Italy, the incidence of healthcare expenditure on GDP has been decreasing in the last years and is forecasted to decline even more in the future
Fonte: Elaborazione The European House - Ambrosetti su dati OECD, 2018
127,6
132,0
100,4
139,1
90
100
110
120
130
140
150
Francia Germania Italia Regno Unito
2010= 100
Health Care Public ExpenditurePro capite 2017 and trend 2010-2017
2.325
1.993 1.283
766 638
Germania Francia EU-14 Regno Unito Italia
4.318
3.6083.091
2.963
Changes in demographic structure
Source: elaboration of The European House – Ambrosetti on Istat data, 2018
Individuals over 65 in Italy (millions),
2018, 2038 and 2058
Individuals in active age (15-64 years) in Italy
(millions), 2018, 2038 and 2058
23% 31% 34% 64% 57% 54%% of total
population
In Italy, the life expectancy is among the highest in Europe, but…
Life expectancy at birth in Europe
(years), 2016
Life expectancy in Italy
(years), 2006 and 2016
Source: The European House – Ambrosetti on Eurostat data, 2018
Ageing population is typically accompanied by an increase of chronic diseases and by a greater pressure on healthcare systems and social-health assistance
Curve of healthcare costs by gender
and age-group
Presence of at least one chronic
disease by age-group (%), 2015
Source: elaboration of The European House - Ambrosetti on Istat and Ragioneria Generale dello Stato data, 2018
Technologies and Innovation: impacts on health
Malattie endocrine emetaboliche
Malattie respiratorie
Neoplasie
Malattie cardiovascolari
Standardized Mortality Rate (per 100,000 inhabitants), 1978-2018
Source: The European House – Ambrosetti su dati Eurostat, Istat e ISS, 2018
-63,7%
-16,9%
-47,1%
-63,2%Malattie endocrine e
metaboliche
Malattie respiratorie
Neoplasie
Malattie cardiovascolari
Standardized prevalences for diseases (per 100,000 inhabitants), 1978-2018
+95,7%
+25,1%
+98,9%
+170,2%
7.300
5.100
9.134
13.780
5.676
2.387
2.900
1.200
243,7
203,5
49,3
30,928,6
93,2
244,8
671,6
Digital and Healthcare: a patient-centered vision
Patient-centered
vision
Integration and
personalization of
care
Improved access and
security/quality of
carer
Efficiency improvement
DIGITAL HEALTH
▪ Personalized
medicine
▪ Evidence based
medicine
▪ Electronic health
records ▪ Telemedicine
▪ Homecare
▪ Mobile
▪ e-prescription
▪ e-booking
▪ Big data
analytics
▪ Data center
▪ Cloud
Source: The European House – Ambrosetti, Meridiano Sanità
A new opportunity era is upcoming
BAUToday BAU growth New business Tomorrow
NEW APPROACH TO BAU GROWTH NEW BUSINESS MODELS
Development of activities of real utility for the S.S. and capable of enabling medium and long-term growth strategies for the most innovative and performing pharmaceutical and healthcare companies based on objective parameters that are more easily measurable with digital
Ideas of new business and service models thanks to mashing products and technologies
Use of development and servitization platforms
Disruption in industry innovation models
THINGS THAT CAN KILL YOU
THINGS THAT CAN KILL YOU
> 1,000 exponential technologies developed in parallel
Technology cost drop
Ecosystem models
New business models
Health, pharma and digital industries convergences
New technologies are transforming the healthcare industry in the same way that they have already transformed other sectors, leading to a convergence of health, pharmaceutical and digital services
IoT &Big data
BlockchainWearable device
EverywhereAnytime
Augmentedreality
ArtificialIntelligenc
e
Biometrics
Patient centricityLong-term projects
(customer total solution)Digital ecosystem
Benefits fo PAYERS and all STAKEHOLDERS
Biotechnology in our daily life… not only wearable
> 275 M$ founding raised
Digitalizing human being
> 300 M$ founding raised > 200 M$ founding raised
New straightway business opportunities
AVAILABLE DIGITAL HEALTH TECHNOLOGIES
TRIALSMANAGEMENT
• Digital platforms• Analytics• Personal device
CONNECTEDPATIENTS
• Continuous monitoring • Alert system• Implanted monitoring
CUSTOMIZEDTHERAPIES
• Fitness• Diets• Life style
DECISIONAL SUPPORT
• Big data• Analytics• Artificial Intelligence
NEW BUSINESS OPPORTUNITIES
PERSONAL WELLNESS
ENTERPRISE WELLNESS
ELDERLY AND ISOLATED
POPULATION
CHRONIC DISEASES(CHF, COPD,
diabete, ecc.)MENTAL HEALTH
HOW TO INTEGRATE ALL OF THESE DECOUPLED DATASETS TO CREATE THE MAXIMUM VALUE FOR BUSINESSES AND
CITIZEN?
New technology approach to data management
NEW BUSINESS MODELS
*
* Major pharmaceutical conglomerates Pfizer and Genentech, together constituting a market cap greater than $300 billion, recently announced the MediLedger blockchain platform, powered by JP Morgan's enterprise-focused, Ethereum-based Quorum, designed to keep counterfeit goods out of medical supply chains
TOKEN
People, devices, servicesWEREABLE BIG DATA & CLOUD ARTIFICIAL INTELLIGENCE
NOT EXHAUSTIVE
BLOCKCHAIN
It allows creating relationship environments through which to develop new business models able to leverage new digital technologies
Which role for Public Health System
From the point of view of the Public Health System, it is necessary to address actions aimed at starting an innovation drive that guarantees efficiency for the public system and avoids the
proliferation of diversified, untested and potentially unsafe digital environments for the citizen!
It is therefore necessary to harmonize the models for the application of digital technology in healthcare, in order to enable the transition
from an experimental logic to a structured logic of widespread use of new digital health services.
Guidelines for the Public Health System
USE OF SOFTWARE AND DEVICES IN CONVENTIONAL HEALTH FACILITIES
1 DEFINITION OF NEW FRAMEWORK FOR THE TESTING AND
IMPLEMENTATION BY HEALTH STRUCTURES OF NEW E-HEALTH
THERAPEUTIC PATHWAYS
2
OPEN ECOSYSTEM APPROAHCES AND PROMOTION OF CENTRE OF EXCELLENCE IN E-HEALTH
3
INTEGRATION OF NEW DATA WITHIN CURRENT SYSTEM
4
New IoT ecosystem in healthcare
▪ Facilitate the exchange of information between patients and the various health service operators
▪ Ensure integration with the FSE on SISS
▪ Ensure autonomy of development by individual health structures and centers of excellence
▪ Enable the "agile" experimentation and the creation of new services
▪ Enhance appropriate partnerships with the technology suppliers
▪ Create an environment conducive to innovation in which to experiment in an "agile" way new proposals coming from the Health System, from industry players or from innovation environments
OBJECTIVES
Daniela Bianco, Partner e Responsabile Health Care Unit
Alessandro Viviani, Principal Expert Digital Strategy
Thank you for your attention